Medtech InsightHot on the heels of the National Health Service (NHS) 10-year health plan, the UK has issued its long-awaited Life Sciences Sector (LSS) plan. Vowing to support economic growth and inward investment,
ScripIt was Groundhog Day on 2 February. That week, any pharmaceutical groundhogs would have emerged from their burrows, glanced at the shadows of tariffs, a global trade war and weak Chinese demand and sc
In Vivo2024 started with early optimism at a potential rebound in deal-making with many unpartnered life sciences assets in Phase III or later (and a lot more at earlier stages), more than $800bn available i
Medtech InsightIllumina Gets FDA Nod For Comprehensive Biomarker Test The FDA has approved a cancer biomarker test and its first two companion diagnostic indications, which manufacturer Illumina, Inc. says can exa